21 July 2020 | News
To promote collaborative research based on equal partnership between the two agencies
Image credit- shutterstock.com
Japan Agency for Medical Research and Development (AMED) has signed a Memorandum of Cooperation (MoC) with the Canadian Institutes of Health Research (CIHR) to promote collaborative research based on equal partnership between the two agencies, further paving the way for joint scientific events.
AMED and CIHR have jointly held two workshops to date, in February 2017 and March 2018, agreeing to promote research that combines advanced technologies and biomedicine. Based on the MoC, AMED and CIHR will promote collaborative research relevant to Advancing Epigenetic Technologies.
AMED has announced a Japan-Canada joint grant call for proposals for research up to three years in duration under the framework of the Strategic International Collaborative Research Program (SICORP). Canada possesses many world-class research centers of excellence in the field of epigenetics, and Japan is looking forward to receiving a large number of competitive research proposals. Furthermore, the scope of the MoC also includes cooperative activities through personnel exchanges, joint seminars, workshops, and other scientific meetings.